Chemotherapy-related cognitive impairment and kidney dysfunction
Open Access
- 13 March 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 40 (Supplement) , ii54-ii63
Abstract
Cancer and kidney diseases (KD) intersect in many ways resulting in worse outcomes. Both conditions are correlated with cognitive impairment, which can be exacerbated in cancer patients by known effects of many antineoplastic drugs on cognition, leading to a phenomenon known as chemotherapy-related cognitive impairment (CRCI). This manifests as poor attention span, disturbed short-term memory, and general mental sluggishness. This literature review explores CRCI and investigates the potential impact of KD on this phenomenon. Additionally, we highlight the shared pathogenetic mechanisms (including neurotoxicity, neuroinflammation, oxidative stress, vascular disease, electrolyte, and acid-base imbalances), clinical presentation and imaging findings between cognitive impairment in KD and CRCI. The disruption of the blood–brain barrier might be a key mechanism for increased brain permeability to anticancer drugs in nephropathic patients with cancer. Based on existing knowledge, we found a potential for heightened neurotoxicity of antineoplastic drugs and a synergistic potentiation of cognitive impairment in cancer patients with KD. However, further translational research is urgently required to validate this hypothesis.Keywords
Funding Information
- COST (CA19127)
This publication has 85 references indexed in Scilit:
- Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFαCellular and Molecular Life Sciences, 2021
- Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney functionCancer Chemotherapy and Pharmacology, 2021
- Cancer-related cognitive impairment (CRCI), depression and quality of life in gynecological cancer patients: a prospective studyArchives of Gynecology and Obstetrics, 2021
- An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)European Journal of Nutrition, 2018
- Altered amygdala-related structural covariance and resting-state functional connectivity in end-stage renal disease patientsMetabolic Brain Disease, 2018
- Guidelines for treatment of renal injury during cancer chemotherapy 2016Clinical and Experimental Nephrology, 2017
- Cytokine‐mediated blood brain barrier disruption as a conduit for cancer/chemotherapy‐associated neurotoxicity and cognitive dysfunctionInternational Journal of Cancer, 2016
- Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancerCancer, 2010
- Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapyBreast Cancer Research and Treatment, 2006
- Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancerSupportive Care in Cancer, 2005